- Home
- CABO vs PCRX Comparison
CABO vs PCRX Comparison
Compare CABO & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABO
- PCRX
- Stock Information
- Founded
- CABO 1980
- PCRX 2006
- Country
- CABO United States
- PCRX United States
- Employees
- CABO N/A
- PCRX N/A
- Industry
- CABO Cable & Other Pay Television Services
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- CABO Telecommunications
- PCRX Health Care
- Exchange
- CABO Nasdaq
- PCRX Nasdaq
- Market Cap
- CABO 1.4B
- PCRX 1.2B
- IPO Year
- CABO N/A
- PCRX 2011
- Fundamental
- Price
- CABO $165.70
- PCRX $25.12
- Analyst Decision
- CABO Hold
- PCRX Buy
- Analyst Count
- CABO 3
- PCRX 9
- Target Price
- CABO $231.00
- PCRX $29.89
- AVG Volume (30 Days)
- CABO 212.4K
- PCRX 745.0K
- Earning Date
- CABO 05-01-2025
- PCRX 05-08-2025
- Dividend Yield
- CABO 7.14%
- PCRX N/A
- EPS Growth
- CABO N/A
- PCRX N/A
- EPS
- CABO N/A
- PCRX N/A
- Revenue
- CABO $1,555,831,000.00
- PCRX $702,772,000.00
- Revenue This Year
- CABO N/A
- PCRX $9.48
- Revenue Next Year
- CABO N/A
- PCRX $11.31
- P/E Ratio
- CABO N/A
- PCRX N/A
- Revenue Growth
- CABO N/A
- PCRX 3.08
- 52 Week Low
- CABO $150.00
- PCRX $11.16
- 52 Week High
- CABO $437.00
- PCRX $31.67
- Technical
- Relative Strength Index (RSI)
- CABO 29.15
- PCRX 48.10
- Support Level
- CABO $150.00
- PCRX $25.08
- Resistance Level
- CABO $187.90
- PCRX $27.34
- Average True Range (ATR)
- CABO 14.80
- PCRX 1.16
- MACD
- CABO -9.49
- PCRX -0.18
- Stochastic Oscillator
- CABO 12.31
- PCRX 48.85
About CABO Cable One Inc.
Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.